• Home
  • Pharmacology
  • Bioreduction in the Activation of Drugs. Proceedings of the by P. Alexander

Bioreduction in the Activation of Drugs. Proceedings of the by P. Alexander

By P. Alexander

Show description

Read or Download Bioreduction in the Activation of Drugs. Proceedings of the Second Biochemical Pharmacology Symposium, Oxford, UK, 25–26 July 1985 PDF

Best pharmacology books

Phytopharmaceuticals in Cancer Chemoprevention

This booklet specializes in the position of normal vitamins in melanoma prevention and treatment. the 1st part covers melanoma epidemiology, melanoma data and present treatments and power toxicities concerned with latest melanoma medicines. the second one part discusses the pathophysiology of melanoma together with mechanistic and molecular features of melanoma biology, etiology of breast melanoma, lung melanoma, prostate melanoma, tobacco and melanoma, gastrointestinal tract cancers and diverse danger components regarding weight problems, workout and getting older.

The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcome

Legislators, newshounds and anxious electorate as a rule, while think about­ ing what to do concerning the plague of heroin habit in huge towns, ask an noticeable query: "Is methadone therapy potent? " this question is a severe one on the grounds that upkeep with methadone is at the present the one prac­ tical replacement to leaving tens of millions (in big apple urban, thousands) of untreated addicts at the streets.

Additional info for Bioreduction in the Activation of Drugs. Proceedings of the Second Biochemical Pharmacology Symposium, Oxford, UK, 25–26 July 1985

Sample text

H o l d e m a n , Cancer Res. 3 5 , 3418 (1975). 18. V . C. Aries, J. S. Crowther, B . S. Drasar, M. J. Hill and R. E . O . Williams, Gut 10, 334 (1969). 19. B . S. Drasar, J. S. Crowther, P. Godard, G. Hawksworth, M. J. Hill, S. Peach, R. E . O . Williams and A . Renwick, Proc. Nutr. Soc. 3 2 , 49 (1973). 20. B . G. Reddy, L. R. Pohl and G. Krishna, Biochem. Pharmac. 2 5 , 1119 (1976). 21. J. C. Mirsalis, T. E . H a m m , J. M. Sherrill and B . E . Butterworth, Nature, Lond. 295, 322 (1982). 22.

00 © 1986 Pergamon Press Ltd. Biochemical Pharmacology, Vol. 35, No. 1, pp. 33-36, 1986. Printed in Great Britain. THE M E T A B O L I C ACTIVATION OF R O N I D A Z O L E [(l-METHYL-5-NITROIMIDAZOLE-2-YL)-METHYL C A R B A M A T E ] TO REACTIVE METABOLITES B Y M A M M A L I A N , CECAL B A C T E R I A L A N D T. FOETUS ENZYMES GERALD T. MIWA, REGINA W A N G , R A U L A L V A R O , JOHN S. WALSH and ANTHONY Y. H. Lu Department of Animal Drug Metabolism, Merck Sharp and D o h m e Research Laboratories, Rahway, NJ 07065, U .

29 Reduction by the gut microflora of animals and man closer animal model of a human gut flora by an alteration in laboratory animals diet (see below). Differences in distribution of the gut flora between animals and man As well as differences in the rates of microbial reductive metabolism between laboratory animals and man there are marked dissimilarities in the distribution of bacteria within the gastrointestinal tracts of different animal species, which have potentially profound consequences for drug metabolism.

Download PDF sample

Rated 4.42 of 5 – based on 42 votes